Oncology/Hematology
News, opinions and meeting coverage in oncology/hematology.
Latest in Oncology/Hematology
Benefit shown in trial of patients flagged for high risk of cardiotoxicity
Time for "long goodbye" to the "burning red devil," say editorialists
78% of patients in prospective study had tumor downstaging with immune checkpoint inhibitors
Trump's pick to lead HHS has called the mineral "industrial waste"
78% of patients in prospective study had tumor downstaging with immune checkpoint inhibitors
Trump's pick to lead HHS has called the mineral "industrial waste"
Oncology/Hematology Case Studies
Rare condition can be deadly without early diagnosis and treatment
Nonspecific presentation impedes early diagnosis of rare indolent tumor in older man
Be aware of the potential for secondary malignancy in relation to LCH diagnosis, researchers urge
More in Oncology/Hematology
More than 40% of adults, half of children met response criteria, majority of responses durable
But absence of significant OS benefit raises questions about long-term benefit, expert says
Other IKCS news: closer look at belzutifan safety, challenges of triplet therapies for RCC
Possible guidance for use of adjuvant immunotherapy in high-risk, non-metastatic disease
Delegates express concerns that PPE doesn't always cover women, who are more at risk of exposure